For example, MDD patients have high levels of proinflammatory mediators such as IL-1, IL-6 and TNF-α, which stimulate the hypothalamic–pituitary–adrenal (HPA) axis to increase the release of glucocorticoids (5). The gene discussed is TNF; the disease is major depressive disorder.